Scientists have developed a computer-based model that may explain how nerve cells become damaged in ALS, and how best to time ...
The Food and Drug Administration meets this week to consider approval of an experimental treatment for Lou Gehrig’s disease, the culmination of a yearslong lobbying effort by patients with the fatal ...
ZURICH, Switzerland, Dec. 5, 2025 /PRNewswire/ -- AL-S Pharma, a clinical-stage biotech company dedicated to the development of AP-101 for the treatment of amyotrophic lateral sclerosis (ALS) today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results